Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tjon

Showing results (401-410 of 441) with videos related to

Pageof 45
Sort By:
Thrombosis and Haemostasis|October 29, 2024
Treatment Modifications in Acute Coronary Syndrome Patients Treated with Ticagrelor: Insights from the FORCE-ACS RegistryNiels M R van der Sangen, Jaouad Azzahhafi, Dean R P P Chan Pin Yin, et al.
Clinical Biochemistry|August 19, 2015
Multi-center evaluation of a user-friendly lateral flow assay to determine IP-10 and CCL4 levels in blood of TB and non-TB cases in AfricaPaul L A M Corstjens, Elisa M Tjon Kon Fat, Claudia J de Dood, et al.
Journal of the American Heart Association|November 8, 2022
Final 5-Year Report of the Randomized BIO-RESORT Trial Comparing 3 Contemporary Drug-Eluting Stents in All-ComersEline H Ploumen, Tineke H Pinxterhuis, Rosaly A Buiten, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|February 5, 2013
Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patientsR E A Tjon Pian Gi, T Ilmarinen, E R van den Heuvel, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 13, 2024
Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndromeWout Willem Antoon van den Broek, Jaouad Azzahhafi, Dean R P P Chan Pin Yin, et al.
Gut|March 23, 2021
Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation ± endoscopic resection: results from the national Dutch database in a 10-year periodSanne van Munster, Esther Nieuwenhuis, Bas L A M Weusten, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2022
Development and External Validation of a Model to Predict Complex Treatment After Radiofrequency Ablation for Barrett's Esophagus With Early NeoplasiaSanne N van Munster, Esther Nieuwenhuis, Raf Bisschops, et al.
Lancet (London, England)|November 4, 2016
Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trialClemens von Birgelen, Marlies M Kok, Liefke C van der Heijden, et al.
Nature Neuroscience|April 10, 2019
Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39Maisa C Takenaka, Galina Gabriely, Veit Rothhammer, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 7, 2021
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics TrialDaniel M F Claassens, Pim W M van Dorst, Gerrit J A Vos, et al.
Pageof 45

Showing results (401-410 of 441) with videos related to

Sort By:
Pageof 45
Thrombosis and Haemostasis|October 29, 2024
Treatment Modifications in Acute Coronary Syndrome Patients Treated with Ticagrelor: Insights from the FORCE-ACS RegistryNiels M R van der Sangen, Jaouad Azzahhafi, Dean R P P Chan Pin Yin, et al.
Clinical Biochemistry|August 19, 2015
Multi-center evaluation of a user-friendly lateral flow assay to determine IP-10 and CCL4 levels in blood of TB and non-TB cases in AfricaPaul L A M Corstjens, Elisa M Tjon Kon Fat, Claudia J de Dood, et al.
Journal of the American Heart Association|November 8, 2022
Final 5-Year Report of the Randomized BIO-RESORT Trial Comparing 3 Contemporary Drug-Eluting Stents in All-ComersEline H Ploumen, Tineke H Pinxterhuis, Rosaly A Buiten, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|February 5, 2013
Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patientsR E A Tjon Pian Gi, T Ilmarinen, E R van den Heuvel, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 13, 2024
Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndromeWout Willem Antoon van den Broek, Jaouad Azzahhafi, Dean R P P Chan Pin Yin, et al.
Gut|March 23, 2021
Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation ± endoscopic resection: results from the national Dutch database in a 10-year periodSanne van Munster, Esther Nieuwenhuis, Bas L A M Weusten, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2022
Development and External Validation of a Model to Predict Complex Treatment After Radiofrequency Ablation for Barrett's Esophagus With Early NeoplasiaSanne N van Munster, Esther Nieuwenhuis, Raf Bisschops, et al.
Lancet (London, England)|November 4, 2016
Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trialClemens von Birgelen, Marlies M Kok, Liefke C van der Heijden, et al.
Nature Neuroscience|April 10, 2019
Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39Maisa C Takenaka, Galina Gabriely, Veit Rothhammer, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 7, 2021
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics TrialDaniel M F Claassens, Pim W M van Dorst, Gerrit J A Vos, et al.
Pageof 45